Pfenex Inc. vs GlaxoSmithKline Biologicals SA

Notice of Refund

Petitioner's Request for Refund

Trial Instituted Document

Ex. 3001

Patent Owner's Response to Petitioner's Explanation of Multiple Petitions Challenging Patent No. 9,422,345 and Ranking Petitions

Petitioner's Explanation of Multiple Petitions Challenging Patent No. 9,422,345 and Ranking of Petitions

Galen Declaration

Madigan 2000, Part 2 of 2

Patent Owner Preliminary Response

Patent Owner Exhibit List

Madigan 2000, Part 1 of 2

van Wely 2001

Hegde 2006

Orr 1999

Terpe 2006

Natale 2008

Papanikou 2007

Hemila 1989

Bishai II 1987

Cabiaux 1988

Choi 2004

Mergulhao 2004

Pappenheimer 1977

Perentesis 1988

Bashai I 1987

Zettlmeissl 1986

Mogensen 2005

Uchida 1971

Petitioner Power of Attorney

Petitioner's Mandatory Change-of-Information Notices

Patent Owner's Mandatory Notices

Patent Owner's Power of Attorney

Notice of Accord Filing Date

U.S. Patent No.: 9,422,345, N. Blais et al., Issued: August 23, 2016

File History of U.S. Patent No.: 9,422,345

S. Inouye and M. Inouye, ¿¿¿Up-promoter mutations in the lpp gene of Escherichia coli,¿¿¿ Nucleic Acids Research 13:3101-3110 (1985) (¿¿¿Inouye¿¿¿)

J. Zhou and R. Petracca, ¿¿¿Secretory expression of recombinant diphtheria toxin mutants in B. subtilis,¿¿¿ Journal of Tongji Medical University 19:253-256 (1999)

U.S. Patent No. 5,264,365, G. Georgiou et al., Issued: November 23, 1993

U.S. Patent No. 5,508,192, G. Georgiou et al., Issued: April 16, 1996

U.S. Patent No. 7,083,945, G. Chen et al., Issued: August 1, 2006

U.S. Patent No. 7,419,783, G. Georgiou et al., Issued: September 2, 2008

S. Dittmann, ¿¿¿Epidemic diphtheria in the newly independent states of the former USSR¿¿¿situation and lessons learned,¿¿¿ Biologicals 25:179-186 (1997)

M. Eaton, ¿¿¿The purification and concentration of diphtheria toxin,¿¿¿ Journal of Bacteriology 31:347-383 (1936)

A. Glenny and B. Hopkins, ¿¿¿Diphtheria toxoid as an immunising agent,¿¿¿ British Journal of Experimental Pathology 4:283-288 (1923)

R. Gupta et al., ¿¿¿Glutaraldehyde inactivated pertussis vaccine: A safe vaccine in the innocuity test,¿¿¿ Vaccine 5:102-104 (1987)

D. O¿¿¿Keefe and R. Collier, ¿¿¿Cloned diphtheria toxin within the periplasm of Escherichia coli causes lethal membrane damage at low pH,¿¿¿ Proceedings of the National Academy of Sciences USA 86;343-346 (1989)

B. Metz Dissertation Thesis ¿¿¿Structural characterisation of diphtheria toxoid,¿¿¿ (Universitat Utrecht) (2005)

R. Collier, ¿¿¿Understanding the mode of action of diphtheria toxin: a perspective on progress during the 20th century,¿¿¿ Toxicon 39:1793-1803 (2001)

R. Collier, ¿¿¿Diphtheria toxin: mode of action and structure,¿¿¿ Bacteriological Reviews 39:54-85 (1975)

T. Uchida et al., ¿¿¿Reconstitution of diphtheria toxin from two nontoxic cross-reacting mutant proteins,¿¿¿ Science 175:901-903 (1972)

P. Braun et al., ¿¿¿Improving protein secretion by engineering components of the bacterial translocation machinery,¿¿¿ Current Opinion in Biotechnology 10:376-381 (1999)

U.S. Patent Application Publication No.: 2009/0010966, C. Davis et al., Published: January 8, 2009

H. Ikemura et al., ¿¿¿Requirement of pro-sequence for the production of active subtilisin E in Escherichia coli,¿¿¿ Journal of Biological Chemistry 262(16):7859-7864 (1987)

R. MacGregor, ¿¿¿Corynebacterium diphtheriae,¿¿¿ in PRINCIPLES AND PRACTICE OF INFECTIOUS DISEASES, 4th Ed., 1865-1872 (Eds. G.L. Mandell, J.E. Bennett, and R. Dolin) (Churchill Livingstone, New York) (1995)

S. Choe et al., ¿¿¿The crystal structure of diphtheria toxin,¿¿¿ Nature 357:216-222 (1992)

S. Dilsen et al., ¿¿¿Fed-batch production of recombinant human calcitonin precursor fusion protein using Staphylococcus carnosus as an expression-secretion system,¿¿¿ Applied Microbiology and Biotechnology 54:361-369 (2000)

J. Ghrayeb et al. ¿¿¿Secretion cloning vectors in Escherichia coli,¿¿¿ The EMBO Journal 10:2437-2442 (1984)

S. Chan et al., ¿¿¿Biosynthesis and periplasmic segregation of human proinsulin in Escherichia coli,¿¿¿ Proceedings of the National Academy of Sciences USA 78:5401-5405 (1981)

H. Hsiung et al., ¿¿¿High-level expression, efficient secretion and folding of human growth hormone in Escherchia coli,¿¿¿ Nature Biotechnology 4:991-995 (1986)

R. Roggenkamp et al., ¿¿¿Expression and processing of bacterial beta-lactamase in the yeast Saccharomyces cerevisiae,¿¿¿ Proceedings of the National Academy of Sciences USA 78:4466-4470 (1981)

J. Choi and S. Lee, ¿¿¿Secretory and extracellular production of recombinant proteins using Escherichia coli.,¿¿¿ Applied Microbiology and Biotechnology 64(5):625-635 (2004)

Indian Patent Application No. 9745/DELNP/2007, E. Mekada et al., Published: June 20, 2008

B. Zuber et al., ¿¿¿Granular layer in the periplasmic space of gram-positive bacteria and fine structures of Enterococcus gallinarum and Streptococcus gordonii septa...,¿¿¿ Journal of Bacteriology 188:6652-6660 (2006)

European Medicines Agency, ¿¿¿Refusal Assessment Report for Cimzia, Procedure No. EMEA/H/C/740,¿¿¿ Document Reference EMEA/176303/2008 (2008)

A. Rietsch and J. Beckwith, ¿¿¿The genetics of disulfide bond metabolism,¿¿¿ Annual Review of Genetics 32:163-184 (1998)

F. Katzen and J. Beckwith, ¿¿¿Disulfide bond formation in periplasm of Escherichia coli,¿¿¿ Methods in Enzymology 348:54-66 (2002).

G. Duffaud et al., ¿¿¿Expression and secretion of foreign proteins in Escherichia coli,¿¿¿ Methods in Enzymology 153:492-507 (1987)

F. Mergulhao et al., ¿¿¿Recombinant protein secretion in Escherichia coli,¿¿¿ Biotechnology Advances 23:177-202 (2005)

A. Ghorpade and L. Garg, ¿¿¿Efficient processing and export of human growth hormone by heat labile enterotoxin chain B signal sequence,¿¿¿ FEBS Letters 330:61-65 (1993)

M. Baeshen et al., ¿¿¿Production of biopharmaceuticals in E. coli: current scenario and future perspectives,¿¿¿ Journal of Microbiology and Biotechnology 25:953-962 (2015)

C. French et al., ¿¿¿Development of a simple method for the recovery of recombinant proteins from the Escherichia coli periplasm,¿¿¿ Enzyme and Microbial Technology 19:332-338 (1996)

A. Skerra and A. Pluckthun, ¿¿¿Assembly of a functional immunoglobulin Fv fragment in Escherichia coli,¿¿¿ Science 240:1038-1041 (1988)

K. Talmadge et al., ¿¿¿Eukaryotic signal sequence transports insulin antigen in Escherichia coli,¿¿¿ Proceedings of the National Academy of Sciences USA 77:3369-3373 (1980)

K. Talmadge et al., ¿¿¿Bacteria mature preproinsulin to proinsulin,¿¿¿ Proceedings of the National Academy of Sciences USA 77:3988-3992 (1980) (¿¿¿Talmadge II¿¿¿)

G. Georgiou and L. Segatori, ¿¿¿Preparative expression of secreted proteins in bacteria: status report and future prospects,¿¿¿ Current Opinion in Biotechnology 16:538-545 (2005)

pET Vector Cloning/Expression Regions (https://web.archive.org/web/19971119174110/http:/www.novagen.com/append/append1.pdf)

U.S. Patent No. 5,917,017, R. Collier et al., Issued: June 29, 1999

H. Thie et al., ¿¿¿SRP and Sec pathway leader peptides for antibody phage display and antibody fragment production in E. coli,¿¿¿ New Biotechnology 25:49-54 (June 2008)

S. Cantrell, ¿¿¿Vectors for the expression of recombinant proteins in E. coli,¿¿¿ Methods in Molecular Biology 235:257-275 (2003)

Patent Owner Preliminary Response in IPR2019-00230, filed February 14, 2019.

Patent Owner Preliminary Response in IPR2019-00241, filed February 14, 2019.

Definition of ¿¿¿capable,¿¿¿ in THE MERRIAM-WEBSTER DICTIONARY, Home and Office ed., p. 75 (Merriam-Webster, Springfield, Massachusetts) (1998)

Curriculum Vitae of George Georgiou, Ph.D.

pET System Tutorial (https://web.archive.org/web/20030408091617/http://novagen.com/SharedImages/TechnicalLiterature/7_pETExp.pdf) (accessed April 15, 2019)

pET-22b(+) Vector Map (https://web.archive.org/web/20030819085202/http://www.novagen.com/docs/NDIS/69744-000.pdf) [with higher resolution image appended from https://plasmid.med.harvard.edu/PlasmidRepository/file/map/pET22b(+).pdf]

pET-25b(+) Vector Map (https://web.archive.org/web/20030516011318/http://novagen.com/SharedImages/TechnicalLiterature/7_TB065.pdf) [with higher resolution image appended from www.synthesisgene.com/vector/pET-25b.pdf]

pET-26b(+) Vector Map (https://web.archive.org/web/20030620093207/http://www.novagen.com/SharedImages/TechnicalLiterature/7_TB071.pdf) [with higher resolution image appended from www.synthesisgene.com/vector/pet-26b.pdf]

PCT Priority Document JP 2005-181314, E. Mekada et al., retrieved from ¿¿¿Related Documents¿¿¿ section at https://patentscope.wipo.int/search/en/detail.jsf?docId=WO2006137398&tab=PCTDOCUMENTS (2006) (accessed April 26, 2019)

pET-27b(+) Vector Map (https://web.archive.org/web/20030622190457/http://www.novagen.com/SharedImages/TechnicalLiterature/7_TB073.pdf) [with higher resolution image appended from http://www.emdmillipore.com/US/en/product...

PCT Publication No.: WO 2006/137398, E. Mekada et al., Published: December 28, 2006, with sequence listing retrieved from ¿¿¿Published International Application¿¿¿ section at https://patentscope.wipo.int/search/en/detail.jsf?docId=WO2006137398...

TolB entry in the Signal Peptide Database at http://signalpeptide.de/index.php?sess=&m=listspdb_bacteria&s=details&id=29110&listname=, creation date July 11, 2003 (accessed May 3, 2019)

Z. Lin et al., ¿¿¿Functional expression of horseradish peroxidase in E. coli by directed evolution,¿¿¿ Biotechnology Progress 15:467-471 (1999)

Parathyroid Hormone entry in the DrugBank database at https://www.drugbank.ca/drugs/DB05829, creation date November 18, 2007 (accessed May 3, 2019)

Declaration of George Georgiou, Ph.D. in Support of Petition for Inter Partes Review of U.S. Patent No. 9,422,345

Petitioner's Power of Attorney

Petition for Inter Partes Review